These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9257765)

  • 1. Circadian variation in urinary excretion of ciprofloxacin after a single-dose oral administration at 1000 and 2200 hours in human subjects.
    Rao VV; Rambhau D; Rao BR; Srinivasu P
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1802-4. PubMed ID: 9257765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
    Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
    Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.
    Kamberi M; Tsutsumi K; Kotegawa T; Kawano K; Nakamura K; Niki Y; Nakano S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):525-9. PubMed ID: 10049262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration.
    Munoz MJ; Llovería P; Santos MP; Abadía AR; Aramayona JJ; Bregante MA
    Vet Q; 1996 Jun; 18(2):45-8. PubMed ID: 8792592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
    Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
    Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).
    Saini SP; Srivastava AK
    Vet Res Commun; 2001 Dec; 25(8):641-9. PubMed ID: 11767010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.
    Washington C; Hou E; Hughes N; Berner B
    Am J Health Syst Pharm; 2006 Apr; 63(7):653-6. PubMed ID: 16554289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients.
    Sánchez Navarro MD; Coloma Milano C; Zarzuelo Castañeda A; Sayalero Marinero ML; Sánchez-Navarro A
    Clin Pharmacokinet; 2002; 41(14):1213-20. PubMed ID: 12405867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension.
    Shah A; Liu MC; Vaughan D; Heller AH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin pharmacokinetics in dogs following oral administration.
    Abadia AR; Aramayona JJ; Muñoz MJ; Pla Delfina JM; Bregante MA
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):505-11. PubMed ID: 8592896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE; Frey FJ; Heizmann P; Brandt R; Weidekamm E
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M; Naber KG; Kinzig-Schippers M; Sörgel F
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
    Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D
    Eur J Clin Microbiol; 1986 Apr; 5(2):179-86. PubMed ID: 2941277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers.
    Washington CB; Hou SY; Campanella C; Hughes N; Brown S; Berner B
    J Clin Pharmacol; 2005 Nov; 45(11):1236-44. PubMed ID: 16239356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.